Hu Wang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Diabetic Nephropathy

Top Venues

ACS pharmacology & translational science

BioMed research international

Journal of cellular physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Lidan Wang, Jingping Geng, Hu Wang
Emerging Landscape of Supercharged Proteins and Peptides for Drug Delivery. ACS pharmacology & translational science 7 (3) (2024)
Lidan Wang, Jingping Geng, Hu Wang
Emerging Landscape of Supercharged Proteins and Peptides for Drug Delivery. ACS pharmacology & translational science 7 (3) (2024)
Jing Wang, Muqing Zhang, Hu Wang
Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies. ACS pharmacology & translational science 7 (8) (2024)
Yu Sun, Lin Li, Jiajun Wang, Huiting Liu, Hu Wang
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches. ACS pharmacology & translational science 7 (1) (2024)
Yu Sun, Lin Li, Jiajun Wang, Huiting Liu, Hu Wang
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches. ACS pharmacology & translational science 7 (1) (2024)
Jing Wang, Muqing Zhang, Hu Wang
Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies. ACS pharmacology & translational science 7 (8) (2024)
Jing Wang, Shoupeng Wei, Jin Zhang, Hu Wang
Association between RIT2 rs16976358 Polymorphism and Autism Spectrum Disorder in Asian Populations: A Meta-analysis. BioMed research international 2023 (2023)
Jingping Geng, Jing Wang, Hu Wang
Emerging Landscape of Cell-Penetrating Peptide-Mediated Organelle Restoration and Replacement. ACS pharmacology & translational science 6 (2) (2023)
Jing Wang, Shoupeng Wei, Jin Zhang, Hu Wang
Association between RIT2 rs16976358 Polymorphism and Autism Spectrum Disorder in Asian Populations: A Meta-analysis. BioMed research international 2023 (2023)
Jingping Geng, Jing Wang, Hu Wang
Emerging Landscape of Cell-Penetrating Peptide-Mediated Organelle Restoration and Replacement. ACS pharmacology & translational science 6 (2) (2023)
Jason Li, Jing Wang, Hu Wang
Emerging Landscape of Preclinical Models for Studying COVID-19 Neurologic Diseases. ACS pharmacology & translational science 6 (10) (2023)
Jing Wang, Shoupeng Wei, Jin Zhang, Hu Wang
Association between RIT2 rs16976358 Polymorphism and Autism Spectrum Disorder in Asian Populations: A Meta-analysis. BioMed research international 2023 (2023)
Xuemei Feng, Hu Wang
Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus. ACS pharmacology & translational science 6 (7) (2023)
Jing Wang, Shoupeng Wei, Jin Zhang, Hu Wang
Association between RIT2 rs16976358 Polymorphism and Autism Spectrum Disorder in Asian Populations: A Meta-analysis. BioMed research international 2023 (2023)
Lidan Wang, Jingping Geng, Hu Wang
Delivery of Oleanolic Acid with Improved Antifibrosis Efficacy by a Cell Penetrating Peptide P10. ACS pharmacology & translational science 6 (7) (2023)
Fengqin Wang, Ying Zhan, Manman Li, Lidan Wang, Austin Zheng, Changbai Liu, Hu Wang, Tao Wang
Cell-Permeable PROTAC Degraders against KEAP1 Efficiently Suppress Hepatic Stellate Cell Activation through the Antioxidant and Anti-Inflammatory Pathway. ACS pharmacology & translational science 6 (1) (2022)
Xiangli Guo, Linlin Chen, Lidan Wang, Jingping Geng, Tao Wang, Jixiong Hu, Jason Li, Chang-Bai Liu, Hu Wang
In silico identification and experimental validation of cellular uptake and intracellular labeling by a new cell penetrating peptide derived from CDN1. Drug delivery 28 (1) (2022)
Fengqin Wang, Ying Zhan, Manman Li, Lidan Wang, Austin Zheng, Changbai Liu, Hu Wang, Tao Wang
Cell-Permeable PROTAC Degraders against KEAP1 Efficiently Suppress Hepatic Stellate Cell Activation through the Antioxidant and Anti-Inflammatory Pathway. ACS pharmacology & translational science 6 (1) (2022)
Lidan Wang, Jingping Geng, Linlin Chen, Xiangli Guo, Tao Wang, Yanfen Fang, Bonn Belingon, Jiao Wu, Manman Li, Ying Zhan, Wendou Shang, Yingying Wan, Xuemei Feng, Xianghui Li, Hu Wang
Improved transfer efficiency of supercharged 36 + GFP protein mediate nucleic acid delivery. Drug delivery 29 (1) (2022)
LinLin Chen, Jiao Wu, Bin Hu, Chang-Bai Liu, Hu Wang
The Role of Cell Division Autoantigen 1 (CDA1) in Renal Fibrosis of Diabetic Nephropathy. BioMed research international 2021 (2021)
Linlin Chen, Xiangli Guo, Lidan Wang, Jingping Geng, Jiao Wu, Bin Hu, Tao Wang, Jason Li, Chang-Bai Liu, Hu Wang
In silico identification and experimental validation of cellular uptake by a new cell penetrating peptide P1 derived from MARCKS. Drug delivery 28 (1) (2021)
Yi Ding, Xueli Zhao, Jingping Geng, Xiangli Guo, Jielan Ma, Hu Wang, Chang-Bai Liu
Intracellular delivery of nucleic acid by cell-permeable hPP10 peptide. Journal of cellular physiology 234 (7) (2018)
Ming Zhang, Xueli Zhao, Jingping Geng, Huiting Liu, Fanhui Zeng, Yanyan Qin, Jason Li, Changbai Liu, Hu Wang
Efficient penetration of Scp01-b and its DNA transfer abilities into cells. Journal of cellular physiology 234 (5) (2018)
Huiting Liu, Xiaoqin Wang, Ran Yang, Wenbing Zeng, Dong Peng, Jason Li, Hu Wang
Recent Development of Nuclear Molecular Imaging in Thyroid Cancer. BioMed research international 2018 (2018)
Jiao Wu, Jason Li, Hu Wang, Chang-Bai Liu
Mitochondrial-targeted penetrating peptide delivery for cancer therapy. Expert opinion on drug delivery 15 (10) (2018)